THE RED HOUSE SURGERY
241 QUEENSWAY, BLETCHLEY, MILTON KEYNES
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 31 | 39 | 79.5% | |
| HF 4 | 2011 | 26 | 33 | 78.8% | |
| HF 4 | 2012 | 24 | 33 | 72.7% | |
| HF 4 | 2013 | 23 | 29 | 79.3% | |
| HF004 | 2014 | 11 | 11 | 100.0% | |
| HF004 | 2015 | 13 | 13 | 100.0% | |
| HF004 | 2016 | 21 | 23 | 91.3% | |
| HF004 | 2017 | 21 | 25 | 84.0% | |
| HF004 | 2018 | 19 | 24 | 79.2% | |
| HF004 | 2019 | 27 | 32 | 84.4% | |
| HF004 | 2020 | 29 | 34 | 85.3% | |
| HF006 | 2021 | 33 | 39 | 84.6% | |
| HF006 | 2022 | 45 | 51 | 88.2% | |
| HF006 | 2023 | 94 | 112 | 83.9% |
